Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Celsius Therapeutics

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
2018
11-50
Cambridge, Massachusetts, United States

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

148.M

Last Funding Amount

83.M

Last Funding Date

24-03-2022

Startup Stage

M&A

Lead Investors

Catalio Capital Management, S32, Third Rock Ventures, Casdin Capital, Amplitude Venture Capital

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information